PL230364A1 - - Google Patents

Info

Publication number
PL230364A1
PL230364A1 PL23036481A PL23036481A PL230364A1 PL 230364 A1 PL230364 A1 PL 230364A1 PL 23036481 A PL23036481 A PL 23036481A PL 23036481 A PL23036481 A PL 23036481A PL 230364 A1 PL230364 A1 PL 230364A1
Authority
PL
Poland
Application number
PL23036481A
Other versions
PL132428B1 (en
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL230364A1 publication Critical patent/PL230364A1/xx
Publication of PL132428B1 publication Critical patent/PL132428B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL1981230364A 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one PL132428B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13484580A 1980-03-28 1980-03-28

Publications (2)

Publication Number Publication Date
PL230364A1 true PL230364A1 (enExample) 1982-03-29
PL132428B1 PL132428B1 (en) 1985-03-30

Family

ID=22465278

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one
PL1981230364A PL132428B1 (en) 1980-03-28 1981-03-27 Proces for preparing novel derivatives of 3-/1-piperidinalkyl/-nh-pyrido-/1,2-a/-pyrimidin-4-one

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1981233902A PL131162B1 (en) 1980-03-28 1981-03-27 Process for preparing novel derivatives of 4h-pyrido /1,2-a/ pyrimidin-4-one

Country Status (5)

Country Link
JP (1) JPS56150091A (enExample)
KR (2) KR850000412B1 (enExample)
PL (2) PL131162B1 (enExample)
SU (1) SU1093251A3 (enExample)
ZA (1) ZA812085B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
DE68926473T2 (de) * 1988-03-28 1996-10-02 Janssen Pharmaceutica Nv Mittel zur Konservierung oder Wiederherstellung der gesunden Haut
EP2252608A4 (en) 2008-02-29 2012-10-03 Vm Discovery Inc METHOD FOR TREATING PAIN SYNDROME AND OTHER SUFFERING
NZ628186A (en) 2012-02-10 2016-03-31 Ptc Therapeutics Inc Compounds for treating spinal muscular atrophy
WO2016196386A1 (en) 2015-05-30 2016-12-08 Ptc Therapeutics, Inc. Methods for modulating rna splicing
SI3386511T1 (sl) 2015-12-10 2021-09-30 Ptc Therapeutics, Inc. Postopki za zdravljenje Huntingtonove bolezni
AU2017363369A1 (en) 2016-11-28 2019-05-30 Ptc Therapeutics, Inc Methods for modulating RNA splicing
BR112019025740A2 (pt) 2017-06-05 2020-06-23 Ptc Therapeutics, Inc. Compostos para tratar a doença de huntington
EA202090034A1 (ru) 2017-06-14 2020-04-16 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы модификации сплайсинга рнк
EP3645121B8 (en) 2017-06-28 2025-06-18 PTC Therapeutics, Inc. Methods for treating huntington's disease
WO2019005980A1 (en) 2017-06-28 2019-01-03 Ptc Therapeutics, Inc. METHODS OF TREATING HUNTINGTON'S DISEASE
EP3774744B1 (en) 2018-03-27 2025-02-12 PTC Therapeutics, Inc. Compounds for treating huntington's disease
BR112020026545A2 (pt) 2018-06-27 2021-03-23 Ptc Therapeutics, Inc. Compostos heterocíclicos e de heteroarila para o tratamento da doença de huntington
SG11202012869SA (en) 2018-06-27 2021-01-28 Ptc Therapeutics Inc Heteroaryl compounds for treating huntington's disease
US11685746B2 (en) 2018-06-27 2023-06-27 Ptc Therapeutics, Inc. Heteroaryl compounds for treating Huntington's disease

Also Published As

Publication number Publication date
PL132428B1 (en) 1985-03-30
KR850000412B1 (ko) 1985-03-26
JPS56150091A (en) 1981-11-20
PL131162B1 (en) 1984-10-31
SU1093251A3 (ru) 1984-05-15
PL233902A1 (enExample) 1982-07-19
JPH0215550B2 (enExample) 1990-04-12
KR850000413B1 (ko) 1985-03-26
ZA812085B (en) 1982-11-24
KR830005220A (ko) 1983-08-03

Similar Documents

Publication Publication Date Title
FR2477052B1 (enExample)
FR2479133B1 (enExample)
GR71717B (enExample)
IN154628B (enExample)
FR2475688B1 (enExample)
FR2474256B1 (enExample)
FR2474666B1 (enExample)
DE3153267A1 (enExample)
FR2494898B1 (enExample)
FR2481763B1 (enExample)
FR2479690B1 (enExample)
FR2479263B1 (enExample)
FR2494375B2 (enExample)
FR2486942B1 (enExample)
FR2492784B1 (enExample)
FR2475091B1 (enExample)
IN154625B (enExample)
FR2473651B1 (enExample)
FR2494084B3 (enExample)
FR2478386B1 (enExample)
FR2495278B3 (enExample)
FR2473170B1 (enExample)
FR2493859B1 (enExample)
FR2492988B1 (enExample)
FR2495167B1 (enExample)